Regulation of transforming growth factor β1 by nitric oxide

Cancer Research

Volumn 59, Issue 9, 1999, Pages 2142-2149

  Vodovotz, Yoram ^a,b   Chesler, Louis ^b   Chong, Hyonkyong ^c   Kim, Seong Jin ^b   Simpson, John T ^d   DeGraff, William ^b   Cox, George W ^e   Roberts, Anita B ^b   Wink, David A ^b   Barcellos Hoff, Mary Helen ^c  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LATENT ASSOCIATED PEPTIDE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; PEPTIDE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NITROSATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

NON-PROGRAMMATIC;

ADENOCARCINOMA; ANIMALS; COCULTURE TECHNIQUES; ENZYME INDUCTION; ENZYME PRECURSORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDRAZINES; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NEOPLASM PROTEINS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITROGEN OXIDES; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; RECOMBINANT FUSION PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0033135025     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Nathan, C. Mechanisms and modulation of macrophage activation. Behring Inst. Res. Commun., 88: 200-207, 1991.
2. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today, 13: 265-270, 1992.
3. Nathan, C., and Xie, Q. Regulation of biosynthesis of nitric oxide. J. Biol. Chem., 269: 13725-13728, 1994.
4. Xie, K., Dong, Z., and Fidler, I. J. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukocyte Biol., 59: 797-803, 1996.
5. Drapier, J., and Hibbs, J. B., Jr. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol., 140: 2829-2838, 1988.
6. Stuehr, D. J., and Nathan, C. F. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med., 169: 1543-1555, 1989.
7. Magrinat, G., Mason, S. N., Shami, P. J., and Weinberg, J. B. Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood, 80: 1880-1884, 1992.
8. Maragos, C. M., Wang, J. M., Hrabie, J. A., Oppenheim, J. J., and Keefer, L. K. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res., 53: 564-568, 1993.
9. Munoz-Fernandez, M. A., Cano, E., O'Donnell, C. A., Doyle, J., Liew, F. Y., and Fresno, M. Tumor necrosis factor-α (TNF-α), interferon-γ, and interleukin-6 but not TNF-β induce differentiation of neuroblastoma cells: the role of nitric oxide. J. Neurochem., 62: 1330-1336, 1994.
10. Yamazaki, A., and Birnboim, H. C. Potentiation of retinoic acid-induced U-937 differentiation into respiratory burst competent cells by nitric oxide donors, Leuk. Res., 19: 325-335, 1995.
11. Pipili-Synetos, E., Papageorgiou, A., Sakkoula, E., Sotiropoulou, G., Fotsis, T., Karakiulakis, G., and Maragoudakis, M. E. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br. J. Pharmacol., 116: 1829-1834, 1995.
12. Kwon, N. S., Stuehr, D. J., and Nathan, C. F. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med., 174: 761-767, 1991.
13. Lepoivre, M., Fieschi, F., Coves, J., Thelander, L., and Fontecave, M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun., 179: 442-448, 1991.
14. Drapier, J., Hirling, H., Wietzerbin, J., Kaldy, P., and Kühn, L. C. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J., 12: 3643-3649, 1993.
15. Cui, S., Reichner, J. S., Mateo, R. B., and Albina, J. E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res., 54: 2462-2467, 1994.
16. Zembala, M., Siedlar, M., Marcinkiewicz, J., and Pryjma, J. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur. J. Immunol., 24: 435-439, 1994.
17. Shrivastava, A., Sodhi, A., and Kumar, R. Activation of murine macrophages by tumor cells. Int. J. Immunopathol. Pharmacol., 8: 45-56, 1995.
18. Fidler, I. J. Macrophages and metastasis-A biological approach to cancer therapy: Presidential address. Cancer Res., 45: 4714-4726, 1985.
19. Nathan, C. F., and Tsunawaki, S. Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effect on the oxidase. In: D. Evered, J. Nugent, and M. O'Connor (eds.), Biochemistry of Macrophages (Ciba Foundation Symposium No. 118), pp. 211-230. London: Pittman Publishing Company, 1986.
20. Roberts, A. B., and Sporn, M. B. The transforming growth factor-betas. In: M. B. Sporn and A. B. Roberts (eds.), Peptide Growth Factors and their Receptors, pp. 419-472. Berlin: Springer-Verlag, 1990.
21. Massagué, J. The transforming growth factor-β family. Annu. Rev. Cell Biol., 6: 597-641, 1990.
22. Wahl, S. M., McCartney-Francis, N., and Mergenhagen, S. E. Inflammatory and immunomodulatory roles of TGF-beta. Immunol. Today, 10: 258-261, 1989.
23. Wahl, S. M. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med., 180: 1587-1590, 1994.
24. Tsunawaki, S., Sporn, M., Ding, A., and Nathan, C. Deactivation of macrophages by transforming growth faetor-β. Nature (Lond.), 334: 260-262, 1988.
25. Vodovotz, Y. Control of nitric oxide production by transforming growth factor-β1: mechanistic insights and potential relevance to human disease. Nitric Oxide Biol. Chem., 1: 3-17, 1997.
26. Vodovotz, Y., Geiser, A. G., Chesler, L., Letterio, J. J., Campbell, A., Lucia, M. S., Sporn, M. B., and Roberts, A. B. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor-β1 null mouse. J. Exp. Med., 183: 2337-2342, 1996.
27. Vodovotz, Y., Kopp, J. B., Takeguchi, H., Shrivastav, S., Coffin, D., Lucia, M. S., Mitchell, J. B., Webber, R., Letterio, J., Wink, D., and Roberts, A. B. Increased mortality, blunted production of nitric oxide, and increased production of tumor necrosis factor-α in endotoxemic transforming growth factor-β1 transgenic mice. J. Leukocyte Biol., 63: 31-39, 1998.
28. Flaumenhaft, R., Kojima, S., Abe, M., and Rifkin, D. B. Activation of latent transforming growth factor β. Adv. Pharmacol., 24: 51-76, 1993.
29. Assoian, R. K., Fleurdelys, B. E., Stevenson, H. C., Miller, P. J., Madtes, D. K., Raines, E. W., Ross, R., and Sporn, M. B. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA, 84: 6020-6024, 1987.
30. Bristol, L. A., Ruscetti, F. W., Brody, D. T., and Durum, S. K. IL-1α induces expression of active transforming growth factor-beta in nonproliferating T cells via a post-transcriptional mechanism. J. Immunol., 145: 4108-4114, 1990.
31. Twardzik, D. R., Mikovits, J. A., Ranchalis, J. E., Purchio, A. F., Ellingsworth, L., and Ruscetti, F. W. γ-Interferon-induced activation of latent transforming growth factor-beta by human monocytes. Ann. NY Acad. Sci., 593: 276-284, 1990.
32. Nunes, I., Shapiro, R. L., and Rifkin, D. B. Characterization of latent TGF-β activation by murine peritoneal macrophages. J. Immunol., 155: 1450-1459, 1995.
33. Chong, H., Vodovotz, Y., Cox, G. W., and Barcellos-Hoff, M. H. Immunocytochemical detection of latent TGF-β activation in cultured macrophages. J. Cell. Physiol. 178: 275-283, 1999.
34. Barcellos-Hoff, M. H., and Dix, T. A. Redox mediated activation of latent transforming growth factor-β1. Mol. Endocrinol., 10: 1077-1083, 1996.
35. Wink, D. A., Hanbauer, I., Grisham, M. B., Laval, F., Nims, R. W., Laval, J., Cook, J., Pacelli, R., Liebman, J., Krishna, M., Ford, P. C., and Mitchell, J. B. The chemical biology of NO. Insights into regulation, protective and toxic mechanisms of nitric oxide. Curr. Top. Cell Biol., 34: 159-187, 1996.
36. Cox, G. W., Mathieson, B. J., Giardina, S. L., and Varesio, L. Characterization of IL-2 receptor expression and function on murine macrophages. J. Immunol., 145: 1719-1726, 1990.
37. Cox, G. W., Melillo, G., Chattopadhyay, U., Mullet, D., Fertel, R. H., and Varesio, L. Tumor necrosis factor-α-dependent production of reactive nitrogen intermediates mediates IFN-τ plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol., 149: 3290-3296, 1992.
38. Ding, A., Nathan, C. F., Graycar, J., Derynck, R., Stuehr, D. J., and Srimal, S. Macrophage deactivating factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-τ. J. Immunol., 145: 940-944, 1990.
39. Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q., and Nathan, C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-β. J. Exp. Med., 178: 605-613, 1993.
40. Sparrow, J., Nathan, C., and Vodovotz, Y. Cytokine regulation of nitric oxide synthase in mouse retinal pigment epithelial cells in culture. Exp. Eye Res., 59: 129-139, 1994.
41. Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskutoff, D. J., and Rifkin, D. B. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem., 216: 276-284, 1994.
42. Danielpour, D., Dart, L. L., Flanders, K. C., Roberts, A. B., and Sporn, M. B. Immunodetection and quantitation of the two forms of transforming growth factor-β (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell. Physiol., 138: 79-86, 1989.
43. Barcellos-Hoff, M. H., Derynck, R., Tsang, M. L., and Weatherbee, J. A. Transforming growth factor-β activation in irradiated murine mammary gland. J. Clin. Invest., 93: 892-899, 1994.
44. Flanders, K. C., Thompson, N. L., Cissel, D. S., Van Obberghen-Schilling, E., Baker, C. C., and Kass, M. E. Transforming growth factor-β1: histochemical localization with antibodies to different epitopes. J. Cell Biol., 108: 653-660, 1989.
45. Ehrhart, E. J., Carroll, A., Segarini, P., Tsang, M. L., and Barcellos-Hoff, M. H. Latent transforming growth factor-β activation in situ: quantitative and functional evidence following low dose irradiation. FASEB J., 11: 991-1002, 1997.
46. Cook, J. A., Kim, S. Y., Teague, D., Krishna, M. C., Pacelli, R., Mitchell, J. B., Vodovotz, Y., Nims, R. W., Christodoulou, D., Miles, A. M., Grisham, M. B., and Wink, D. A. Convenient colorimetric and fluorimetric assays for S-nitrosothiols. Anal. Biochem., 238: 150-158, 1996.
47. Albina, J. E. On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukocyte Biol., 58: 643-649, 1995.
48. Kim, S. J., Angel, P., Lafyatis, R., Hattori, K., Kim, K. Y., Sporn, M. B., Karin, M., and Roberts, A. B. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell. Biol., 10: 1492-1497, 1990.
49. Brown, P. D., Wakefield, L. M., Levinson, A. D., and Sporn, M. B. Physiocochemical activation of recombinant latent transforming growth factor-βs 1, 2, and 3. Growth Factors, 3: 35-43, 1990.
50. Anzano, M. A., Roberts, A. B., De Larco, J. E., Wakefield, L. M., Assoian, R. K., Roche, N. S., Smith, J. M., Lazarus, J. E., and Sporn, M. B. Increased secretion of type β transforming growth factor accompanies viral transformation of cells. Mol. Cell. Biol., 5: 242-247, 1985.
51. Coffey, R. J., Jr., Shipley, G D., and Moses, H. L. Production of transforming growth factors by human colon cancer lines. Cancer Res., 46: 1164-1169, 1986.
52. Coffey, R. J., Jr., Goustin, A. S., Mangelsdorf Soderquist, A., Shipley, G. D., Wolfshohl, J., Carpenter, G., and Moses, H. L. Transforming growth factor α and β expression in human colon cancer lines: implications for an autocrine model. Cancer Res., 47: 4590-4594, 1987.
53. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringmann, T. S., and Berger, W. H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
54. Niitsu, Y., Urushizaki, Y., Terui, K., Mahara, K., Kohgo, Y., and Urushizaki, I. Expression of TGF-β in adult T cell leukemia. Blood, 71: 263-266, 1988.
55. Schwarz, L. C., Wright, J. A., Gingras, M., Kondiah, P., Danielpour, D., Pimentel, M., Sporn, M. B., and Greenberg, A. H. Aberrant TGF-β production and regulation in metastatic malignancy. Growth Factors, 3: 115-127, 1990.
56. Terui, T., Niitsu, Y., Mahara, K., Fujisaki, Y., Urushizaki, Y., Mogi, Y., Kohgo, Y., Watanabe, N., Ogura, M., and Saito, H. The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood, 75: 1540-1548, 1990.
57. Murata, J., Corradin, S. B., Felley-Bosco, E., and Juillerat-Jeanneret, L. Involvement of a transforming growth factor β-like molecule in tumor cell-derived inhibition of nitric oxide synthesis in cerebral endothelial cells. Int. J. Cancer, 62: 743-748, 1995.
58. Takiuchi, H., Tada, T., Li, X., Ogata, M., Ikeda, T., Fujimoto, S., Fujiwara, H., and Hamaoka, T. Particular types of tumor cells have the capacity to convert transforming growth factor β from a latent to an active form. Cancer Res., 52: 5641-5646, 1992.
59. Horimoto, M., Kato, J., Takimoto, R., Terui, T., Mogi, Y., and Nitsu, Y. Identification of a transforming growth factor β-1 activator derived from a human gastric cancer cell line. Br. J. Cancer, 72: 676-862, 1995.
60. 2. J. Immunol., 153: 1674-1686, 1994.
61. Maeda, H., Tsuru, S., and Shiraishi, A. Improvement of macrophage dysfunction by administration of anti-transforming growth factor-β antibody in EL4-bearing hosts. Jpn. J. Cancer Res., 85: 1137-1143, 1994.
62. Assreuy, J., Cunha, F. Q., Liew, F. Y., and Moncada, S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharmacol., 108: 833-837, 1993.
63. Sheffler, L. A., Wink, D. A., Melillo, G., and Cox, G. W. Exogenous nitric oxide regulates IFN-γ plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages. J. Immunol., 155: 886-894, 1995.
64. Seyler, I., Appel, M., Devissaguet, J., Legrand, P., and Barratt, G. Modulation of nitric oxide production in RAW 264.7 cells by transforming factor-β and interleukin-10: differential effects on free and encapsulated immunomodulator. J. Leukocyte Biol., 62: 374-380, 1997.
65. Borgerding, R. A., and Murphy, S. Expression of inducible nitric oxide synthase in cerebral endothelial cells is regulated by cytokine-activated astrocytes. J. Neurochem., 65: 1342-1347, 1995.
66. Lander, H. M., Sehajpal, P., Levine, D. M., and Novogrodsky, A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol., 150: 1509-1516, 1993.
67. Vallette, G., Jarry, A., Branka, J., and Laboisse, C. L. A redox-based mechanism for induction of interleukin-1 production by nitric oxide in a human colonie epithelial cell line (HT29-C1.16E). Biochem. J., 313: 35-38, 1996.
68. Marcinkiewicz, J., Grabowska, A., and Chain, B. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol., 25: 947-951, 1995.
69. Hill, J. R., Corbett, J. A., Kwon, G., Marshall, C. A., and McDaniel, M. L. Nitric oxide regulates interleukin I bioactivity released from murine macrophages. J. Biol. Chem., 271: 22672-22678, 1996.
70. Rothe, H., Hartmann, B., Geerlings, P., and Kolb, H. Interleukin-12 gene expression of macrophages is regulated by nitric oxide. Biochem. Biophys. Res. Commun., 224; 159-163, 1996.
71. Villarete, L. H., and Remick, D. G. Nitric oxide regulation of 1L-8 expression in human endothelial cells. Biochem. Biophys. Res. Commun., 211: 671-676, 1995.
72. Brown, Z., Robson, R. L., and Westwick, J. L-arginine/nitric oxide pathway: a possible signal transduction mechanism for the regulation of the chemokine IL-8 in human mesangial cells. Adv. Exp. Med. Biol., 351: 65-75, 1993.
73. Andrew, P. J., Harant, H., and Lindley, J. D. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem. Biophys. Res. Commun., 214: 949-956, 1995.
74. Stamler, J. S., Jaraki, O., Osborne, J., Simon, D I., Keaney, J., Vita, J., Singel, D., Valeri, C. R., and Loscalzo, J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA, 89:7674-7677, 1992.
75. Stamler, J. S., Simon, D. I., Jaraki, O., Osborne, J. A., Frances, S., Mullins, M., Singel, D., and Loscalzo, J. S-Nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc Natl. Acad. Sci. USA, 89: 8087-8091, 1992.
76. Jia, L., Bonaventura, C., Bonaventura, J., and Stamler, J. S. S-Nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature (Lond.), 380: 221-226, 1996.
77. Lander, H. M., Sehajpal, P. K., and Novogrodsky, A. Nitric oxide signaling: a possible role for G proteins. J. Immunol., 151: 7182-7187, 1993.
78. Mirza, U. A., Chait, B. T., and Lander, H. M. Monitoring reactions of nitric oxide with peptides and proteins by electrospray ionization-mass spectrometry. J. Biol. Chem., 270: 17185-17188, 1995.